FDA-EVALUATING › Historical Revision Information
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] - Guidance for Industry and Food and Drug Administration Staff

FDA-EVALUATING - 2011 DRAFT - SUPERSEDED
Show Complete Document History


The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] - Guidance for Industry and Food and Drug Administration Staff


This document comes with our free Notification Service, good for the life of the document.

This document is available in either Paper or PDF format.

ORDER



Document Number

FDA-EVALUATING

Revision Level

2011 DRAFT

Status

Superseded

Publication Date

Dec. 27, 2011

Page Count

48 pages